Fri, Feb 27, 2015, 12:58 PM EST - U.S. Markets close in 3 hrs 2 mins


% | $
Quotes you view appear here for quick access.

OneBeacon Insurance Group, Ltd. Message Board

snogreen 229 posts  |  Last Activity: 6 hours ago Member since: Aug 30, 2000
  • Here's a possible. Dr. Chopp of Henry Ford just published kind of a summary of TB in neuro. His work last 5 years was funded largely by the NIH. NIH likes Chopp. In the 2000's NIH gave him $6.5 million to study stem cells and near. No drug or trial came of that , that I can find. for last 5 years, Chopp studied TB 3. And it now seems he has a drug ready for trial. So logical he goes back to NIH? Checkd NIH. They have a Grant cycle that had a JAN 25 app deadline....then a couple reviews, and if you get it, late September you get the money. NIH has poured millions with Dr. Chopp and HF. And they think they have a drug ready for trial in neuro. My guess that is the path...NIH grant to do a small neuro trial.....and RGRX not look for a partner until after he does it. See if works.. If Chopp does small Phs 2 in house at HF....can be reasonably $ done. If results look good, I can name 4 BIG pharma that would be all over him. but as usual, we don't have a clue what goes on. deadline to apply NIH has Jan 25. Makes sense why he published the summary article TB 4 euro. I post it again, next.

  • Reply to

    shares piled on ask at open

    by thebasiles777 Feb 5, 2015 9:33 AM
    snogreen snogreen Feb 5, 2015 9:41 AM Flag

    Like I said, the MM isn't going to give up the short narrative in RGRX. Couple days ago they shorted 256,000 out of 273,000 traded. They are short a few million RGRX, easily..maybe more. Just a fact that they will be here, and show size short offered most of the time, because they believe RGRX a POS and RGRX will go down in flames. Good abstracts don't move RGRX at of the eye rights deal in US didn't move too much......NITE shortd 256,000 INTO THAT NEWS! The only news that will get RGRX a lot higher will be actuall good trial results from Lee's.....I think they will be the first to start a trial. Koreans are slow.....and they won't do a USA eye NK trial until they see what happens in results with Lee's. You want RGRX higher? Get Lee's trial started ASAP. Lee's is the real deal and will have respect. I guess it's apossible a BIG buyer takes out the BIG short offers..but I doubt it. Lee's trial start is the key. Then pray it works.

  • Reply to

    sems koreans did not buy more

    by snogreen Feb 4, 2015 10:03 AM
    snogreen snogreen Feb 5, 2015 9:27 AM Flag

    Then if you believe that, (that they are swimming in money) why didn't G Tree jump at the opportunity to buy 5.5 million RGRX shares at 15 cents? Answer is? they don't have the money to do so! And that was only abouty $875,000.They owe $1 million for TB 4 USA rights, they have to pay for a Phs 3 in korea......That has to be a couple million? And I don't know where they will find $3-$4 million to do a USA eye NK orphan trial..phase 3's are expensive...

    Look at the financials of G Tree.....they LOSE MONEY EVERY YEAR! Gtree will probably proceed with Korea trial, but no way will Gtree put up the BIG money for USA eye NK phase 3 UNTIL they see what the results are in Lee's big trial. HEY! I am not bummed out theye didn't buy! Less dilution for us!

  • Reply to

    sems koreans did not buy more

    by snogreen Feb 4, 2015 10:03 AM
    snogreen snogreen Feb 4, 2015 8:30 PM Flag

    Please show the documentation of this "thesis": You state:

    "THE INVESTORS whoever they are that bought into the company last November have the financial means to fund the trials, who cares how they do it,"

    I have searched Bloomberg and Reuters, and I can find NO such news that mysterious hidden investors pumpoed huge moneyt into G Tree. Nothing, Nada. HOW DO YOU KNOW THEY HAVE THE HUGE FINANCAL RESOURCES???? NO STOCK WAS ISSUED . WHO IS IT?There are 18 million shares of G Tree outstanding.

    It also should cause you pause, in that G Tree appears to have REFUSED to exercise the right to buy 5.5 million RGRX shars at 15 cents. That deal expired and RGRX has a SEC duty to state if there was a 5.5 million share sale. Nothing. So contrary to your hype........the Koreans do NOt have the money you say. If they DID, wouldn't they have exercised???? Nor did RGRX state clearly WHEN G Tree would pay RGRX the two tranches of $500k for USA eye riights. WHEN ? this year? NEXT YEAR??? NO ONE KNOWS!

    Everything I or geez asks are logical things You're just lookin like a pumper... hyper . But I will say I am happy to see 20 cents again.

  • I don't think bo has posted this.....Form 4 filing going back to end of December...29th.....seems that Goldstein during mid 2014 gave away a good portion of his RGRX stock. he did it in two blocks, or 250,000 each.....500,000 shares total...he still has a buch...I think 1 million she and options too. I don't take it as a negative. Godlstein double dipped salaries MANy years between G.W. univ and RGRX..both full time salaries.... I'm sure he is in fine $ shape. So if he wanted to give away 250k shares to family or charity.....time to do it would be when any possible gift tax woudl be lowest....while RGRX is low. Each 250k shares was worth about $32,000..filing won't say where it a charity of family. If he has an older child who is married, he could give husband & wife $14,000 each of RGRX stock.........around 13 28,000 of the 32,000 value woudl be tax free. Or, If Goldstein wanted to help a time to do that is to give 250,000 shares away when it is like 13 cents. If RGRX goes BK, teh chaity doesn't lose, it was fee stock. if RGRX ever goes to $1 or $ makes good

  • Seems that the Koreans did not exercise the right to buy 5,500,000 shares at 0.15. Doesn't surprise me. I didn't think they have that much money. They have to do a korea trial and they just bought eye TB 4 rights in US for $1 million. And BTW? In that press release, it said the $1 million was in two tranches, but they were not specific on WHEN the money would come.

    Not bad news though. Koreans have to save whatever money they have for trials and we don't get diluted by another 5.5 million shares.

  • Reply to

    To many chickens coming

    by takithom Feb 3, 2015 1:32 PM
    snogreen snogreen Feb 3, 2015 4:46 PM Flag

    You will be right eventually on chicken prices. Down. But won't be for a while, and even so, PPC will soon be (after earnings Q4) trading for about 8.5 x earnings. So you MUST admit, PE of 8.5 is reflecting lower chicken in later 2015. It's built in pretty much now. I avoid PPC because the $1.5 billion dividend was a horrible decision. THINK about it. PPC does a 180. Seven months ago they'tre ready to expand out of chicken with hillshioe. Good. Willing to spend over $6 billion. Fast forward to now, and JBS raids PPC for $1.2 billion which all but negates PPC ever doing a large multi billion deal. PPC will have to debt up about $2 billion. In december, PPC was debt free. the WORST thing is that PPC owners are BLIND to - is that PPC is now the piggy bank for JBS. JBS needed $1.2 billion from PPC, so JBS COULD BUY THE NEXT MULTI BILLION DEAL! it should by all rights have been PPC's! So now PPC will be debted up - at the top of chicken prices and PPC won't be able to diversify in a big way OUT of just chicken, now. JBS saw to that. JBS took $1.2 billion of PPC (YOU shareholders money) to do their next deal! I posted her often, I'm out of PPC but I bought a lot of JBSAY! JBS will be the winner, not PPC.

  • snogreen by snogreen Feb 3, 2015 9:27 AM Flag

    Securities traded on the over-the-counter bulletin board (“OTCBB”) are not subject to any short sale price tests and are therefore do not rely on an exception from such price tests. As such, they need not be marked “short exempt.”

    Rule 203(b)(2)(iii) provides an exception from the locate requirement for short sales effected by market makers, but only in connection with bona-fide market making activities. Rule 203(c)(1) provides that the term “market maker” has the same meaning as in Section 3(a)(38) of the Exchange Act, which defines “market maker” as “any specialist permitted to act as a dealer, any dealer acting in the capacity of a block positioner, and any dealer that, with respect to a security, holds itself out (by entering quotations in an inter-dealer communications system or otherwise) as being willing to buy and sell such security for its own account on a regular or continuous basis.”

    The term “bona-fide market making” refers to bona-fide activities described in Section 3(a)(38) of the Exchange Act. Whether activity is “bona-fide” will depend on the facts and circumstances of the particular activity. However, the Adopting Release sets forth examples of activities that would not be considered to be “bona-fide market making activities.” (69 FR at 48015).

  • Reply to

    finra numbers

    by thebasiles777 Feb 2, 2015 7:20 PM
    snogreen snogreen Feb 3, 2015 6:32 AM Flag

    I'm not incoherent or over served. I am right. And Finkel Dope has no clue what he is doing. Nor does he have any clue how MM's do what they do, and the result of what they do puts RGRX into such a penny stock that funding is almpst impossible on decent terms. In a way, MM"s can aqua someone topwards bankruptcy, by shprting so much stock DOWN TO PENNIES, that funing impossible I KNOW this sounds liek stupid retail shouting "NAKED SHORTS". but it is true! NITE and probably a couple other MM's are short MILLIONS of RGRX. yet the SEC reporst there is ZERO share short in RGRX. Take YESTERDAY! 373,000 shares trade, 356,000 shorted. CAN IT GET ANY CLEARER? IT HAS BEEN GOING ON FOR YEARS NOW. The MM's, largely NITE just sit and SELL, SELL, SELL, SELL SHORT SHORT SHORT until they make it look SO BAD that no one will ever touch RGRX. The MM's also POSITION trade this huge RGRX short, which is AGAINST SEC market maker rules. Which means NITE is CHEATING and STEALINg.. I anm not blowing smoke here. I've harped for years this is going on......and YESTERDAY my pot BOILED OVER IN ANGER AT THE INCOMPETANCE OF FINKEL DOPE.........WHY HASN'T HE CALLED THE SEC? THE SEC WILL NOT LISTEN TO US........THEY WILL TAKE HIS CALL. EVIDENCE IS CLEAR. NITE IS SCAMMING RGRX. FINKEL DOPE DOES NOTHING.....

  • Reply to

    finra numbers

    by thebasiles777 Feb 2, 2015 7:20 PM
    snogreen snogreen Feb 2, 2015 8:37 PM Flag

    Opps, typo:

    "If today does not clue you in FINKEL DOPE-DOPE-DOPE........373,000 shares trade.....256,000 shares were shorted. are wortheless manager......piece of ***."

    I'm so sorry. It wa 356,000 shorted today,noit 256,000. 373,00 trade, 356,00 shorted..naked short and not reported.

    TO THE WASHINGTON DC LAWYER WHO READS THIS BOARD AND OWNS it time to sue FINKELSTEIN AND RGRX? I think so. That may drag Joe McNAys good name down too.. You are horrible, greedy **** Finkelstein. Do something RIGHt for shareholders, JUST ONCE. All you do is collect $$$..collect salary.collect options and stuff. We collect your messes and lose....every time.

  • Reply to

    finra numbers

    by thebasiles777 Feb 2, 2015 7:20 PM
    snogreen snogreen Feb 2, 2015 8:27 PM Flag

    Hey Finkelstein....Finkel Jerk..Finkel DOPE.....Just WHEN are you going to do A SINGLE thing right for shareholders? Sure, you got this fly-by-night Korean outfit. Congrats. But they don't havb the necessary money needed as far as I can see. And All I see of the $$ they give is that it makes sure that no matter what happens YOU get your $125,000.00 salary and I bet bonus. HOW MANY YEARS have I posted and TOLD makers are NOT ALLOWED to POSITION TRADE outside the normal course of market, sell, buy, sell daily. There is not enough volume in RGRX to buy, sell. So all NITE and other MM's do is SELL, SELL, SELl, SELl, SELL..SHORT.....SHORT..SHORT... and they do so in the market maker account - naked shorting, not borrowed,, and not reported to SEC.. The SEc RULES STATE that if you take postion trades OUTSIDE of normal daily marlet making activities, a MM must MOVE that position OUT of the MM account and into a seperate trade account. And when it get's shifted OUT of a MM account, they have to BORROW stock and report the short to the SEC.

    If today does not clue you in FINKEL DOPE-DOPE-DOPE........373,000 shares trade.....256,000 shares were shorted. are wortheless manager......piece of ***.

    We have a good lawyer here who owns a lot. MAybe he should call the SEC. Today was ridiculous. MAtter of fact? the last 3-4 years of the MM's doing it are ridiculous..

  • WOW! Some kind iof report from FINRA. 373,000 shares traded. Of that 356,000 were SHORTED. Our MM does NOt give up. Amazing thing is the SEC reports there is SERO...0..shares short in RGRX. I used to think NITE was short a couple million as a position trade (against the NASDAQ rules).......after today and what they have done over 2 years.I bet it is closer to 4 million short that NO ONE knows about. Finkel DOPE....wht ARE YOU NOT CALLING THE SEC??? It is illegal for NASADQ rules to position trade short like this. THEY ARE NAked short and do NOT report!

  • Reply to

    buyer controlling the action... now last .18

    by thebasiles777 Feb 2, 2015 11:30 AM
    snogreen snogreen Feb 2, 2015 11:47 AM Flag

    I don't think the MM short is going to cover anytime soon...they've been at it for so long now and done very well $$$. One spike up isn't going to change their minds....they believe RGRX a POS and eventulally BK..they've seen it before with so many tiny penny stock bios...they won't cover right now......but wonder if they offer more stock to hold it.

  • Reply to

    300,000 shares at .16 sold

    by thebasiles777 Feb 2, 2015 11:23 AM
    snogreen snogreen Feb 2, 2015 11:44 AM Flag

    very curious to see how much, if any, was shorted there.

  • Reply to

    Will Koreans buy 5.5 million shs?

    by snogreen Feb 2, 2015 9:54 AM
    snogreen snogreen Feb 2, 2015 10:10 AM Flag

    sorry! Wrong board.

    PPC shouldn't be down this much. Uhhh.

  • Will the Koreans exercise right to buy 5.5 million shares at 0.15? I don't know. They may not. They control the US eye indication now.. But G-Tree doesn't have the money you all think. I think their market cap is about 30million and they have capital maybe 12 million. They have to pay RGRX 1 million. they have to pay and do Korea trial.....a US Eye Nk phs 3 could cost $4-$6 million fom where are they getting money? They may not exercise to buy stock. who knows. If they do, we get more dilution and JJ get''s his 125k salary I won't mind if they don't buy..less dilution and more money thaty have to do trials.

  • Reply to

    Heart and Neurological Indications

    by bocamp1 Jan 31, 2015 2:54 PM
    snogreen snogreen Feb 2, 2015 7:24 AM Flag

    I hope you're right. Sad thing is that RGRX has pretty good patents in heart and neuro already given. That's usually a holdback for a big pharma looking to partner a drug. They won't do it and spend $$$ if they on't own the IP. RGRX pretty much does. The closest to possibility woudl be neuro..cuz' Henry Ford has done over 5 years of work on it. The last abstract I posted by them seemed to be interesting in that it was a summary of all the work they've done. So I wonder if they are done with their pre clinical stuff. And they a few years ago were tagged by RGRX that they would do a small physician sponsoired euro trial. But Henry Ford appears to have no interest. If they don't, it makes it a harder sell to a big pharma. But who knows. HF does get respect. The heart stuff is no where cl;se to the pre clinical work HF has done.....heart is a long shot. Other sad thing is that RGRX put themselves in a box, in terms of what they can now get $ for a TB 4 partner deal in neuro or heart. No big pharma will logically pay more than what Koreans just paid for all TB 4 in eye area..and that was $1 million plus royalty and a small back end JV slice. The Koreans stole it. They got Orphan Status Eye Nk with an FDA approved 'GO" phase 3. for $1 million. For the life of me I don't understand why Ora Inc couldn't sell it to one of their $$$$ eye clients. $1 million to them is maybe a few housrs expenses, of their total yearly R&D spending.

  • Reply to

    Now Costco is offering $5.00 a share

    by fstout57 Jan 30, 2015 1:30 PM
    snogreen snogreen Jan 30, 2015 1:58 PM Flag

    Hey, don't blame it on JBS or call them corrupt. You just didn't do your homework. It is clear as a bell that JBS Brazil owns 75% of PPC. that means PPC operates at their wishes and desires - NOT yours!. And JBS told PPC that they wanted a $1,200,000,000.00 dividend and that PPC woudl just have to really debt up it's balance sheet to pay them. Minority holders had no say.

    The second point is why trash JBS? Because you have every chancve to buy into JBS! If what JBS did to PPC was not healthy for PPC, then buy the company that benefits.....JBSAY! I shiftd out of much of my PPC a few months ago, and I bought JBSAY. The stock is up, but the currency declines in Brazil temper that. So be warned. but I am very happy I did and I buy more JBSAY. I sold all I had left of PPC when I saw that bombshell of the dividend , basically to fund JBS.... explained all to me. JBS didn't give a hoot how badly they loaded up PPC with debt, JBS wanted $1.2 now I'm out of PPC and probably won't get back...but I am a lot bigger in JBSSAY....and I still play PPCanyway, because JBSAY owns 75% of PPC

  • Reply to


    by kpolhj Jan 30, 2015 9:26 AM
    snogreen snogreen Jan 30, 2015 12:43 PM Flag

    JBS is not in as bad shape as you think. Yes, they are heavy debted and high coupons. Ballpark it around $14 billion debt. But I recall JBS has about $4.8 billion cash Q3?

    Second, JBS is knocking the numbers out of the park. 70-75% of their revenues are in US DOLLARS......The Brazilian Real has gone from 2.40 to 2.69......JBS keeps the dollars in US for safety, but for accounting translate that back into brazil figs at 2.69 reals....explosive. Furthermore, with the huge downdraft in the Real, ...even tho'70-75% of JBS revenues in US dollars....the weak Real is boosting JBS exports HUGE. McDonalds and KFC buy a lot from JBS. Beef prices sky high for US beef McD can buy JBS beef brazil at a 15-20% DISCOUNt because of the Dollar vs Real currency. JBS Brazil is minting money right now............and collapsed oil prices reduce their costs too.

    I do not believe JBS sucked out $1.2 billion from PPC to bolster balance sheet. I believe JBS took it because they needed it for another large acquisition. They sit on $4.8 billion cash (last Q, more in Q4)..and the $1.2 billion from PPC will push their cash to over $6 billion. JBS has a deal target, imo.

  • Reply to


    by kpolhj Jan 30, 2015 9:26 AM
    snogreen snogreen Jan 30, 2015 11:53 AM Flag

    No, it was NOT equal benefit. JBS sucked out of PPC's balance sheet, which was PRSTINE beforehand...$1,200,000,000.00 and JBS will use that money to buy another company thatPPC shoudl have bought.

14.77-0.02(-0.14%)12:58 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.